Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00699803 · ClinicalTrials.gov registry record · Phase 2
Study of T-PRED(TM) Compared to Pred Forte(R)
A Phase 2 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 2
- Development phase
- 64
- Enrollment target
NCT00699803 is a Phase 2 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 64 participants.
The verdict
NCT00699803, a Phase 2 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 64 participants
- Enrollment target
Study Summary
Study of T-PRED(TM) compared to Pred Forte(R)
Interventions
- DRUG Pred Forte
- DRUG T-PRED
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00699803
The ClinicalTrials.gov registry entry for NCT00699803 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pred Forte is the first listed.
NCT00699803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00699803 about?
NCT00699803 is a clinical study titled "Study of T-PRED(TM) Compared to Pred Forte(R)". Study of T-PRED(TM) compared to Pred Forte(R)
What is the current status of trial NCT00699803?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 64 participants. The study started on 2008-05. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00699803?
The interventions under investigation include: Pred Forte (DRUG), T-PRED (DRUG).
Who is sponsoring clinical trial NCT00699803?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.